Medical News

RSS
Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

WNBA, Africare, NBA and ExxonMobil launch "Power Forward" to develop health, leadership in Nigeria

WNBA, Africare, NBA and ExxonMobil launch "Power Forward" to develop health, leadership in Nigeria

ORC to develop paper-based sensors to detect biomarkers in cancer patients

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

Orthopaedic specialist offers tips to prevent painful holiday season

Orthopaedic specialist offers tips to prevent painful holiday season

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

State highlights: Tenn. gov. hesitates on Medicaid expansion; Calif. primed for big 2014 health care ballot; abortion law fight in Texas rages on

State highlights: Tenn. gov. hesitates on Medicaid expansion; Calif. primed for big 2014 health care ballot; abortion law fight in Texas rages on

University of Wisconsin scientist to present revolutionary stem cell technology to Australian bioindustry

University of Wisconsin scientist to present revolutionary stem cell technology to Australian bioindustry

New technology to give voice to people with severe speech impairment

New technology to give voice to people with severe speech impairment

Patients treated with high-risk endoscopic procedure less likely to be admitted in hospital

Patients treated with high-risk endoscopic procedure less likely to be admitted in hospital

Long-term use of PDE3 inhibitors can lead to increased risk for sudden cardiac death

Long-term use of PDE3 inhibitors can lead to increased risk for sudden cardiac death

Annual rates of CPR training vary widely across the U.S.

Annual rates of CPR training vary widely across the U.S.

D.C. insurance commissioner fired after questioning Obama's fix for 'canceled plans'

D.C. insurance commissioner fired after questioning Obama's fix for 'canceled plans'

Study confirms therapeutic potential of inhibiting Aurora-A in cancer treatment

Study confirms therapeutic potential of inhibiting Aurora-A in cancer treatment

MOH scaling up innovative EONC model to save lives of mothers and newborns

MOH scaling up innovative EONC model to save lives of mothers and newborns

Eating tree nuts reduces risk of pancreatic cancer, shows women’s health study

Eating tree nuts reduces risk of pancreatic cancer, shows women’s health study

New report examines impact of federal and state policy decisions on community health centers

New report examines impact of federal and state policy decisions on community health centers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.